Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

39.92
-0.1850-0.46%
Volume:400.10K
Turnover:15.80M
Market Cap:3.84B
PE:-20.41
High:40.16
Open:39.85
Low:38.90
Close:40.10
52wk High:42.68
52wk Low:23.23
Shares:96.27M
Float Shares:94.37M
Volume Ratio:0.54
T/O Rate:0.42%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9561
EPS(LYR):-1.2849
ROE:-16.22%
ROA:-11.54%
PB:3.21
PE(LYR):-31.06

Loading ...

Ideaya Biosciences price target lowered to $63 from $65 at Truist

TIPRANKS
·
Jul 07

Ideaya Biosciences is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 07

RBC Capital Adjusts IDEAYA Biosciences Price Target to $48 From $53, Maintains Outperform Rating

MT Newswires Live
·
Jul 07

Ideaya Biosciences Grants Inducement Stock Options for 98,000 Shares at $36.29 Each

Reuters
·
Jun 26

Ideaya Biosciences Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jun 26

IDEAYA Biosciences Shareholders Back Leadership, Governance Changes

TIPRANKS
·
Jun 24

IDEAYA Biosciences shareholders ratified PwC as auditor for 2026

Reuters
·
Jun 24

Ideaya Biosciences elects CEO Yujiro Hata as chairman

TIPRANKS
·
Jun 17

IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of Its Board of Directors

THOMSON REUTERS
·
Jun 17

IDEAYA Biosciences - Terry Rosen to Serve as Lead Independent Director

THOMSON REUTERS
·
Jun 17

Press Release: IDEAYA Biosciences Announces Yujiro S. Hata Elected Chairman of its Board of Directors

Dow Jones
·
Jun 17

Is IDEAYA Biosciences (IDYA) Quietly Reframing Its MTAP Strategy With the New IDE892 Combinations?

Simply Wall St.
·
Jun 16

IDEAYA Biosciences' Phase 1 Clinical Trial of Lung, Pancreatic Cancer Treatment Enrolls First Patient

MT Newswires Live
·
Jun 15

Ideaya Biosciences enrolls first patient in IDE892 trial

TIPRANKS
·
Jun 15

IDEAYA enrolls first patient in Phase 1/2 trial of PRMT5 inhibitor IDE892 with MAT2A drug IDE397 in MTAP-deleted tumors

Reuters
·
Jun 15

IDEAYA Biosciences Price Target Maintained With a $58.00/Share by Wedbush

Dow Jones
·
Jun 12

IDEAYA Biosciences Raises $324 Million in Equity Offering

TIPRANKS
·
Jun 11

Ideaya Biosciences Closes $345 Million Public Offering

MT Newswires Live
·
Jun 11

IDEAYA Biosciences prices $345 million public offering at $27 a share

Reuters
·
Jun 11

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09